Search

Bisphosphonates are widely used in the treatment of osteoporosis and contribute to the reduction of bone fractures. Ibandronate (IBN) is a highly potent, nitrogen-containing bisphosphonate, which is administered orally or intravenously at extended dosing intervals. Vitamin D or active vitamin D3 derivatives are also used in the treatment of osteoporosis, and are often used in combination with other drugs. In this study, we investigated the effect of treatment with the combination of once-monthly s.c. dosing of IBN plus once-daily oral eldecalcitol (ELD), an active vitamin D3 derivative, using aged ovariectomized (OVX) rats. Treatment was started the day after OVX, and analyses were performed 4, 8, and 12weeks thereafter by determination of bone markers, bone mineral density, biomechanical properties, and histomorphometry. The combination treatment showed a synergistic effect in increasing both lumbar and femoral BMD, and resulted in a significant increase in bone ultimate load. The combination of IBN plus ELD acted synergistically to reduce bone resorption, whereas bone formation did not decrease any more than with monotherapy with either IBN or ELD. Bone formation independent of bone resorption (a process known as ‘minimodeling’) was not changed in vehicle treated OVX rats despite the increase in bone turnover. ELD upregulated minimodeling, which was however not diminished in the combination treatment. In conclusion, treatment with the combination of IBN plus ELD was beneficial in the treatment of osteoporosis in aged OVX rats. It exhibited a synergistic inhibitory effect on bone resorption and keeps bone formation at the level of sham controls. This uncoupling of bone resorption/bone formation was affected, to some extent, by minimodeling-based bone formation which is independent of bone resorption. This combination regimen which showed synergistic effect on BMD and bone ultimate load without inhibition of bone formation may be beneficial in long-term osteoporosis treatment to prevent bone fractures.

Maklamicin, which is produced by the endophytic Micromonospora sp. NBRC 110955, is a spirotetronate-class antibiotic possessing anti-microbial activity against Gram-positive bacteria, and has several unique structural features different from other spirotetronates. Here we describe identification and characterization of the maklamicin biosynthetic (mak) gene cluster through draft genome sequencing, genomic library screening, and gene disruption. Sequence analysis revealed that a plausible maklamicin cluster resides in a 152 kb DNA region encoding 46 open reading frames, 24 of which can be assigned roles in the biosynthesis of polyketide backbone, spirotetronate or peripheral moieties, self-resistance and the regulation of maklamicin production. Disruption of the polyketide synthase (PKS) genes makA1 or makA4 resulted in a complete loss of maklamicin production, indicating that the type I modular PKS system is responsible for the biosynthesis of maklamicin. The mak gene cluster contained a set of biosynthetic genes for the formation of a tetronate moiety, which were found to be highly conserved in the gene clusters for spirotetronate antibiotics. Based on the estimated biosynthetic genes, we propose the biosynthetic pathway for maklamicin. Our findings provide not only insights on the biosynthetic mechanism of the unique structures in maklamicin, but also useful information to facilitate a comparative analysis of the spirotetronate biosynthetic pathways to expand the structural repertoire.

Protein-protein interactions (PPIs) play key roles in all cellular processes and hence are useful as potential targets for new drug development. To facilitate the screening of PPI inhibitors as anticancer drugs, the authors have developed a high- throughput screening (HTS) system using an in vitro protein fragment complementation assay (PCA) with monomeric Kusabira-Green fluorescent protein (mKG). The in vitro PCA system was established by the topological formation of a functional complex between 2 split inactive mKG fragments fused to target proteins, which fluoresces when 2 target proteins interact to allow complementation of the mKG fragments. Using this assay system, the authors screened inhibitors for TCF7/β-catenin, PAC1/PAC2, and PAC3 homodimer PPIs from 123,599 samples in their natural product library. Compound TB1 was identified as a specific inhibitor for PPI of PAC3 homodimer. TB1 strongly inhibited the PPI of PAC3 homodimer with an IC 50 value of 0.020 µM and did not inhibit PPI between TCF7/β-catenin and PAC1/PAC2 even at a concentration of 250 µM. The authors thus demonstrated that this in vitro PCA system applicable to HTS in a 1536-well format is capable of screening for PPI inhibitors from a huge natural product library. (Journal of Biomolecular Screening XXXX:xxx-xxx)

In recent times, the apparent population decline of the southern bent-wing bat (Miniopterus schreibersii bassanii) at Bat Cave, Naracoorte has been ascribed to pesticide use in the region, following the finding of organochlorine and orgaonophosphate insecticide residues in bat guano. Adult southern bent-wing bats were collected from Bat Cave and Starlight Cave in 2003. Organochlorine contaminants were detected in all carcass samples: p,p'-DDE was by far the most dominant contaminant with concentrations ranging from 11,000 to 59,000ngg(-1), followed by p,p'-DDT (110-1600ngg(-1)), p,p'-DDD (35-620ngg(-1)), summation operatorPCBs (33-490ngg(-1)), summation operatorchlordane and related compounds (7.9-270ngg(-1)), HCB (1.6-120ngg(-1)), HP epox. (3.1-230ngg(-1)), TCPMOH (3.8-38ngg(-1)), summation operatorHCHs (1.4-9.6ngg(-1)), and TCPMe (0.1-4.2ngg(-1)) (all values on lipid-weight basis). No significant difference in DDE, DDD, DDT, summation operatorDDT, summation operatorPCB, trans-chlordane, heptachlor epoxide, trans-nonachlor, alpha-HCH, beta-HCH, gamma-HCH, TCPMOH or TCPMe concentrations were observed either between sexes within sites, or between sites (p0.05). However, there were significant differences in HCB and oxychlordane concentrations between sexes and between sites (p0.05), between site differences in cis-nonachlor concentrations in male bats (p0.05), and cis-chlordane concentrations between sexes at Starlight Cave, and between males of each site (p0.05). There were also significant differences in the liver concentrations of some metals between sexes within sites (Ag, Cd, Co, Cu, Pb, Se, Zn), and between sites (Ag, Cd, Co, Cu, Hg, Pb, Se, V, Zn). Clustering or grouping of sites was observed when the OC data was expressed on a lipid-weight basis. These inter-site differences in OC concentrations reflect local exposure over a period of time, and do not unambiguously support any suggestion that we are witnessing incipient speciation. However, for conservation purposes, it may be prudent to assume that there are two sub-populations of M. s. bassani feeding in different locations in this region of southern Australia, rather than the single homogeneous population suggested by genetic studies.

Laminin-5 is an important basement membrane protein that regulates cell adhesion and motility. It was previously found that the gamma2 chain of laminin-5 is transiently expressed in embryonic cartilage. This suggests a possible role of laminin-5 in chondrogenesis. Here, we examined this possibility using the murine teratocarcinoma cell line ATDC5. ATDC5 cells transiently and weakly expressed laminin-5 when they were stimulated for differentiation. Exogenous laminin-5 in either insoluble or soluble form strongly inhibited the differentiation phenotypes, i.e. formation of cartilaginous cell aggregates and production of chondrogenic marker proteins through its integrin-binding domain LG3 in the alpha3 chain. Laminin-5 had no effect on cell growth. In addition, we found that the laminin-5 with the 105-kDa, processed gamma2 chain suppressed differentiation more strongly than one with the 150-kDa gamma2 chain. This indicated that the proteolytic processing of gamma2 chain regulated the activity of laminin-5. However, a gamma2 chain short arm fragment had no effect on the chondrogenesis, and it rather suppressed the differentiation at excessive concentrations. These results suggest that laminin-5 and its processing modulate chondrogenic differentiation during development.

(2 S , 3 R , 4 S )-4-[L-N-[(2 S )-3-ethylsulfonyl-2-(1-naphthylmethyl) propionyl]norleucyl]amino-5-cyclohexyl-1-morpholino-2,3-pentanediol(BW-175) was synthesized stereospecifically.

The key intermediates, 2-substituted-3-hydroxypropionic acids 1 , of the potent renin inhibitors were synthesized enantioselectively starting from 2-substituted-l,3-propanediols via chemo-enzymatic reaction.

BW-175 is a newly synthesized renin inhibitor which is a nonpeptidic, norleucine analog. Its IC50 values for renin activity in human, squirrel monkey, marmoset, dog, hog, rabbit and rat plasma were 3.3, 6.6, 2.4, 42, 110, 86 and 3500 nM, respectively, and 26 microM for cathepsin D. Pepsin and angiotensin converting enzyme were hardly inhibited at 10(-4) M. BW-175 showed an oral bioavailability of 2.8% at 10 mg/kg and 9.7% at 30 mg/kg in rats. In normotensive, furosemide-treated high-renin marmosets, BW-175 (30 mg/kg p.o.) caused an intensive reduction in plasma renin activity and plasma angiotensin I formation, associated with a reduction in systolic blood pressure of 10-20 mm Hg for 2 hours.